Biotech Insider Traded On $3.5B Novartis Deal, Feds Say
By Elliot Weld · May 23, 2025, 5:25 PM EDT
A former board member at Chinook Therapeutics orchestrated an insider-trading scheme after learning about Novartis' plans to purchase the biotech company for $3.5 billion in 2023, according to an indictment announced...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login